Breaking News Instant updates and real-time market news.

TOWR

Tower International

$30.87

12.595 (68.92%)

12:00
07/12/19
07/12
12:00
07/12/19
12:00

Tower International rises 69.0%

Tower International is up 69.0%, or $12.60 to $30.87.

TOWR Tower International
$30.87

12.595 (68.92%)

08/28/18
WELS
08/28/18
NO CHANGE
WELS
Tentative U.S./Mexico trade deal a starting point for auto stock recovery, says Wells Fargo
Wells Fargo analyst Richard Kwas believes the U.S./Mexico tentative trade deal is a positive for the automotive space in the interim. In his view, part of the recent underperformance has come from trade uncertainty. NA centric supplier names like Magna (MGA) and Tower International (TOWR) could be the biggest beneficiaries. MGA does have material revenue exposure to Canada and therefore the absence of Canada in a final agreement would create some level of complication for the company relative to the rest of supplier group, he notes. Kwas believes the decision to limit non Mexico/U.S. content to 25% of vehicle value coupled with the 40%-45% minimum threshold for $16/hour manufacturing jobs should stabilize or increase U.S. share of vehicle production.
10/30/18
ROTH
10/30/18
NO CHANGE
Target $36
ROTH
Buy
Tower International price target lowered to $36 from $43 at Roth Capital
Roth Capital analyst Matt Koranda lowered his price target for Tower International to $36 from $43 to reflect incremental pro-forma lease-related debt. The analyst notes that the company delivered solid Q3 results and reiterated the fundamental drivers of its 2018 outlook. He reiterates a Buy rating on the shares.
02/13/19
GHSC
02/13/19
INITIATION
GHSC
Neutral
Tower International initiated with a Neutral at Seaport Global
02/13/19
ROTH
02/13/19
NO CHANGE
Target $32
ROTH
Buy
Tower International selloff appears overdone, says Roth Capital
Roth Capital analyst Matt Koranda said Tower International's Q4 results were "noisy," which he attributes to the divestiture of its Europe segment and reinstatement of Brazil. Though the 2019 adjusted EBITDA outlook was "slightly soft," Koranda said he doesn't view that as a source of long-term concern. On the other hand, the 2020 outlook was well ahead of his expectations and gives a window into the company's "intrinsic earnings power," said the analyst, who thinks the selloff in the shares has been overdone. He reiterates a Buy rating on Tower International with a $32 price target, down from $37 previously.

TODAY'S FREE FLY STORIES

SCHW

Charles Schwab

$41.62

1.34 (3.33%)

07:17
07/17/19
07/17
07:17
07/17/19
07:17
Recommendations
Charles Schwab analyst commentary  »

Charles Schwab net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

IAC

IAC

$231.54

-2.55 (-1.09%)

07:17
07/17/19
07/17
07:17
07/17/19
07:17
Hot Stocks
IAC to invest $250M in Turo car sharing marketplace »

IAC has agreed to invest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWOU

2U

$38.60

-0.34 (-0.87%)

07:17
07/17/19
07/17
07:17
07/17/19
07:17
Initiation
2U initiated  »

KeyBanc bullish on 2U,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.06

0.06 (0.32%)

07:15
07/17/19
07/17
07:15
07/17/19
07:15
Conference/Events
Alector management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 09

    Sep

VEGPF

Vectura Group

$0.00

(0.00%)

07:14
07/17/19
07/17
07:14
07/17/19
07:14
Hot Stocks
Vectura Group continues to seek partner for VR647 Phase III development »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$45.50

1.44 (3.27%)

07:13
07/17/19
07/17
07:13
07/17/19
07:13
Downgrade
Nu Skin rating change  »

Jefferies downgrades Nu…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

VEGPF

Vectura Group

$0.00

(0.00%)

07:13
07/17/19
07/17
07:13
07/17/19
07:13
Hot Stocks
Vectura Group board approves capital return of approx. GBP50M »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,152.97

2.58 (0.22%)

, GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

07:13
07/17/19
07/17
07:13
07/17/19
07:13
Recommendations
Alphabet, Alphabet Class A, Facebook, Twitter analyst commentary  »

KeyBanc expects…

GOOG

Alphabet

$1,152.97

2.58 (0.22%)

GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

FB

Facebook

$203.87

-0.06 (-0.03%)

TWTR

Twitter

$38.00

-0.68 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 08

    Aug

  • 27

    Oct

CSII

Cardiovascular Systems

$44.00

-1.9 (-4.14%)

07:12
07/17/19
07/17
07:12
07/17/19
07:12
Conference/Events
Cardiovascular Systems management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

  • 09

    Sep

  • 12

    Sep

VEGPF

Vectura Group

$0.00

(0.00%)

07:11
07/17/19
07/17
07:11
07/17/19
07:11
Hot Stocks
Vectura Group confirms R&D investment priorities »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$45.30

-1.4 (-3.00%)

07:10
07/17/19
07/17
07:10
07/17/19
07:10
Recommendations
Wells Fargo analyst commentary  »

Wells Fargo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

VMW

VMware

$172.25

0.03 (0.02%)

07:09
07/17/19
07/17
07:09
07/17/19
07:09
Recommendations
VMware analyst commentary  »

VMware estimates likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

SMMT

Summit Therapeutics

$1.35

-0.06 (-4.26%)

07:09
07/17/19
07/17
07:09
07/17/19
07:09
Hot Stocks
Summit presents preclinical data on SMT-571 at STI & HIV World Congress »

Summit Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHSI

Guardion Health Sciences

$0.97

-0.03 (-3.02%)

07:07
07/17/19
07/17
07:07
07/17/19
07:07
Hot Stocks
Guardion Health Sciences receives patent for MapcatSF in Hong Kong »

Guardion Health Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPZ

Domino's Pizza

$246.55

-23.42 (-8.68%)

07:06
07/17/19
07/17
07:06
07/17/19
07:06
Recommendations
Domino's Pizza analyst commentary  »

Domino's Pizza…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PSTI

Pluristem

$0.57

0.0319 (5.87%)

07:05
07/17/19
07/17
07:05
07/17/19
07:05
Hot Stocks
Pluristem, U.S. DoD to announce data from studies testing PLX-R18 »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$215.57

4.02 (1.90%)

, MS

Morgan Stanley

$44.41

-0.01 (-0.02%)

07:05
07/17/19
07/17
07:05
07/17/19
07:05
Recommendations
Goldman Sachs, Morgan Stanley analyst commentary  »

Goldman Sachs price…

GS

Goldman Sachs

$215.57

4.02 (1.90%)

MS

Morgan Stanley

$44.41

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 15

    Oct

ACIU

AC Immune

$5.62

0.1 (1.81%)

, LLY

Eli Lilly

$108.81

0.36 (0.33%)

07:04
07/17/19
07/17
07:04
07/17/19
07:04
Hot Stocks
AC Immune initiates Phase 1 study of ACI-3024 »

AC Immune SA (ACIU)…

ACIU

AC Immune

$5.62

0.1 (1.81%)

LLY

Eli Lilly

$108.81

0.36 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 09

    Sep

  • 16

    Sep

  • 02

    Oct

ANIX

Anixa Biosciences

$4.14

-0.01 (-0.24%)

07:03
07/17/19
07/17
07:03
07/17/19
07:03
Hot Stocks
Anixa Biosciences partnering with Cleveland Clinic for breast cancer vaccine »

Anixa Biosciences has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRKR

Bruker

$49.61

-0.02 (-0.04%)

07:03
07/17/19
07/17
07:03
07/17/19
07:03
Hot Stocks
Bruker comments on block trade transaction »

Bruker has been advised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 17

    Jul

07:02
07/17/19
07/17
07:02
07/17/19
07:02
General news
MBA Mortgage Applications Composite Index data reported »

Week of 7/12 MBA Mortgage…

NCNA

NuCana

$9.80

-0.05 (-0.51%)

07:02
07/17/19
07/17
07:02
07/17/19
07:02
Hot Stocks
NuCana doses first patients in Phase I study of NUC-7738 »

NuCana announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHOOF

Choom Holdings

$0.00

(0.00%)

07:02
07/17/19
07/17
07:02
07/17/19
07:02
Hot Stocks
Choom Holdings to acquire 19.9% equity interest of Coastal Green »

Choom is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNC

PNC Financial

$138.66

-1.52 (-1.08%)

07:01
07/17/19
07/17
07:01
07/17/19
07:01
Hot Stocks
PNC Financial sees FY19 revenue up at higher end of low single digits vs. FY18 »

Sees average loans up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 16

    Oct

PNC

PNC Financial

$138.66

-1.52 (-1.08%)

07:00
07/17/19
07/17
07:00
07/17/19
07:00
Hot Stocks
PNC Financial sees Q3 NII 'stable' vs. Q2 »

Sees average loans up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 16

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.